$22.62
+
$0.55 (2.43%)
End-of-day quote: 04/30/2024
NasdaqGS:ARWR
Arrowhead Pharmaceuticals Annual Report
| Year | Year | 2023 | 2022 | 2010 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$240.74M | $243.23M | $0.00M | $138.29M | $87.99M | $168.80M | $16.14M | $31.41M | $0.16M | $0.38M | $0.18M | $0.29M | $0.15M | |
| GM % | Gross Margin % |
|
100.00% | 100.00% | 0.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | |
| OM | Operating Margin |
|
-85.16% | -73.39% | 0.00% | -107.77% | -105.87% | 36.25% | 0.00% | -117.79% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| EPS | Earnings Per Share |
|
$0.00 | $-1.92 | $-1.67 | $-1.36 | $-0.84 | $0.69 | $-0.65 | $-0.47 | $-1.31 | $-1.43 | $-1.15 | $-1.18 | $-1.90 | $0.90 |
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| PR % | Payout Ratio % |
|
-0.00% | -0.00% | 0 | -0.00% | -0.00% | 0 | 0 | 0 | 0 | 0 | 0 | -0.00% | 0 | |
| Sha. | Shares |
|
107.31m | 105.96m | 7.17m | 104.33m | 102.38m | 95.51m | 88.51m | 74.79m | 69.75m | 59.54m | 54.66m | 32.49m | 13.58m | |
| OCF | Operating Cash Flow |
|
$-153.89M | $-136.13M | $-7.70M | $171.31M | $-95.39M | $173.04M | $-47.22M | $-23.94M | $-64.43M | $-65.71M | $-35.42M | $-19.03M | $-15.34M | |
| FCF | Free Cash Flow |
|
$-330.63M | $-188.91M | $0.00M | $147.66M | $-107.34M | $161.03M | $-48.64M | $-31.86M | $-68.29M | $-67.68M | $-37.13M | $-19.33M | $-15.82M | |
| FCFS | Free Cash Flow Per Share |
|
$-3.10 | $-1.79 | $-1.20 | $1.42 | $-1.07 | $1.72 | $-0.58 | $-0.43 | $-1.12 | $-1.18 | $-0.79 | $-0.81 | $-1.42 |
